Hepatic and splenic tuberculosis

Changed by Bruno Di Muzio, 7 Apr 2018

Updates to Article Attributes

Body was changed:

Hepatic and splenic tuberculosis refers to tuberculosis affecting the liver and the spleen. It generally occurs due to haematogenous spread from the primary site of infection, commonly from pulmonary tuberculosis.

Pathology

Two types of lesions are known:

  • micronodular (common)
  • macronodular (rare)

Radiographic features

Ultrasound

Nonspecific features are usually seen, including hepatosplenomegaly and abscesses 3.

There may be small hypoechoic nodules (miliary type) or a larger hypoechoic mass-like areaareas 2,3.

CT
  • micronodular (miliary) type3
    • multiple
    • small low attenuation areas with central enhancement (acute stage)
    • calcification (chronic stage)
  • macronodular type3
    • single or large tumour-like mass
    • diffuse hepatosplenomegaly

Differential diagnosis

  • for micronodular type
  • for macronodular type

See also

  • -<p><strong>Hepatic and splenic tuberculosis </strong>refers to <a href="/articles/tuberculosis">tuberculosis</a> affecting <a href="/articles/liver">liver</a> and <a href="/articles/spleen-1">spleen</a>. It generally occurs due to spread from the primary site of infection, commonly from <a href="/articles/tuberculosis-pulmonary-manifestations-1">pulmonary tuberculosis</a>.</p><h4>Pathology</h4><p>Two types of lesions are known:</p><ul>
  • +<p><strong>Hepatic and splenic tuberculosis </strong>refers to <a href="/articles/tuberculosis">tuberculosis</a> affecting the <a href="/articles/liver">liver</a> and the <a href="/articles/spleen-1">spleen</a>. It generally occurs due to haematogenous spread from the primary site of infection, commonly from <a href="/articles/tuberculosis-pulmonary-manifestations-1">pulmonary tuberculosis</a>.</p><h4>Pathology</h4><p>Two types of lesions are known:</p><ul>
  • -</ul><h4>Radiographic features</h4><h5>Ultrasound</h5><p>Nonspecific features are usually seen. There may be small hypoechoic nodules (miliary type) or a larger hypoechoic mass-like area <sup>2</sup>.</p><h5>CT</h5><p><!--[if gte mso 9]><xml>
  • +</ul><h4>Radiographic features</h4><h5>Ultrasound</h5><p>Nonspecific features are usually seen, including hepatosplenomegaly and abscesses <sup>3</sup>.</p><p>There may be small hypoechoic nodules (miliary type) or larger hypoechoic mass-like areas <sup>2,3</sup>.</p><h5>CT</h5><p><!--[if gte mso 9]><xml>
  • -<li>micronodular type<ul>
  • -<li>low attenuation areas with central enhancement (acute stage)</li>
  • +<li>micronodular (miliary) type <sup>3</sup><ul>
  • +<li>multiple</li>
  • +<li>small low attenuation areas with central enhancement (acute stage)</li>
  • -<li>macronodular type<ul>
  • +<li>macronodular type <sup>3</sup><ul>
  • -</ul><p><strong>Differential diagnosis</strong></p><ul>
  • +</ul><h5>MRI</h5><ul>
  • +<li>
  • +<strong>T1: </strong>lesions usually have iso signal compared to the background parenchyma</li>
  • +<li>
  • +<strong>T2: </strong>mixed signal with hyperintense areas</li>
  • +<li>
  • +<strong>C+ (Gd): </strong> variable, reflecting the phases of the disease</li>
  • +</ul><h4>Differential diagnosis</h4><ul>
  • -<li>lymphoma</li>
  • +<li><a href="/articles/splenic-lymphoma">lymphoma</a></li>
  • -<li>metastases</li>
  • +<li><a href="/articles/splenic-metastases">metastases</a></li>
  • -<li>abscess</li>
  • +<li><a href="/articles/splenic-abscess">abscess</a></li>
  • -<li>primary malignancy</li>
  • +<li><a href="/articles/splenic-lesions-and-anomalies">primary malignancy​</a></li>
  • -</ul><h4>See also</h4><ul><li><a href="/articles/gastrointestinal-tuberculosis">gastrointestinal tuberculosis</a></li></ul><p><!--EndFragment--></p>
  • +</ul><p><!--EndFragment--></p>

References changed:

  • 3. Lee HJ, Kim JW, Hong JH, Kim GS, Shin SS, Heo SH, Lim HS, Hur YH, Seon HJ, Jeong YY. Cross-sectional Imaging of Splenic Lesions: RadioGraphics Fundamentals | Online Presentation. (2018) Radiographics : a review publication of the Radiological Society of North America, Inc. 38 (2): 435-436. <a href="https://doi.org/10.1148/rg.2018170119">doi:10.1148/rg.2018170119</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/29528823">Pubmed</a> <span class="ref_v4"></span>

ADVERTISEMENT: Supporters see fewer/no ads